Karen Bulock,
Associate Director/Vice President
Dr. Bulock has twenty years of experience in discovery project management and assay development. During her tenure at RXi Pharmaceuticals, Dr. Bulock has managed several key programs leading to the discovery and preclinical development of RXI-109 for dermal scarring and fibrosis. Prior to this she spent several years leading small molecule drug discovery programs at CytRx, Corporation. Dr. Bulock received a Ph.D. in Pharmacology from Yale University.
|
|
|
